NASDAQ
93.39USD
+1.74 (+1.90%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
4.3B
P/E
—
EPS
—
Beta
0.34
52W range
61.96-150.44
Day range
88.81–94.70
Open
92.25
Prev close
91.65
Volume
1.5M
Avg volume
713.4K
Dividend
0.00
IPO
2025-11-06
https://www.fool.com/coverage/filings/2026/07/12/a-billiontoone-insider-sold-801-shares-as-revenue-jumped-84/ · 7/12/2026+0.80
https://www.zacks.com/stock/news/2926117/does-billiontoone-blln-have-the-potential-to-rally-37-as-wall-street-analysts-expect?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|consensus_price_target-2926117 · 5/25/2026+0.60
https://www.globenewswire.com/news-release/2026/05/06/3289347/0/en/billiontoone-reports-first-quarter-2026-results-and-raises-2026-revenue-guidance.html · 5/6/2026+1.00
https://www.zacks.com/stock/news/2878996/billiontoone-blln-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|nfm-2878996 · 3/5/2026+0.80
https://www.prnewswire.com/news-releases/billiontoone-expands-northstar-platform-with-launch-of-two-new-add-on-liquid-biopsy-applications-for-northstar-select-302683416.html · 2/10/2026+1.00
https://www.prnewswire.com/news-releases/billiontoone-announces-dual-launch-of-unity-expanded-red-blood-cell-and-platelet-fetal-antigen-nipts-extending-its-leadership-in-setting-the-new-standard-in-prenatal-care-302682790.html · 2/9/2026+1.00
https://www.prnewswire.com/news-releases/gunderson-dettmer-represents-long-time-client-billiontoone-in-its-upsized-273-1-million-initial-public-offering-302607889.html · 11/6/2025+1.00
BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
